Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by ROBERTS BRIAN KENNETH, Vice-Président Senior, Développement Clinique. Insider active across 1 company, notably Rezolute, Inc.. In total, 13 reports have been logged. Split: 11 buys · 0 sell. Total volume traded: €143k. Activity tracked since 4 May 2022. The latest transaction was filed on 2 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
21,052 shares@ US$3.800.019% mcap95.9% of flowCommon StockSEC:0001567619-22-009701:0
Ideal exit: 29 Jan 2023 (T+270)
13 of 13 declarations
About ROBERTS BRIAN KENNETH
ROBERTS BRIAN KENNETH is the Senior Vice President of Clinic Development at Rezolute, Inc. He is responsible for leading the company's clinical development initiatives. His role is essential in ensuring the effectiveness and compliance of clinical programs.